Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
Menu

Contact Us
If you have any questions or feedback please contact us.
 Back to Profile

Ann Thor

Concepts (458)

Concepts are derived automatically from a person's publications.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Breast Neoplasms
72
2023
2411
3.860
 Why?
Neoplasms, Germ Cell and Embryonal
8
2026
76
2.630
 Why?
Testicular Neoplasms
8
2026
108
2.600
 Why?
Metformin
10
2018
328
1.990
 Why?
Lymph Node Excision
6
2026
173
1.770
 Why?
Tamoxifen
11
2023
193
1.590
 Why?
Receptors, Estrogen
17
2020
405
1.440
 Why?
Thyroid Hormones
2
2023
69
1.390
 Why?
Seminoma
3
2026
20
1.330
 Why?
Receptor, ErbB-3
8
2016
48
1.210
 Why?
Biomarkers, Tumor
17
2024
1334
1.200
 Why?
Lymphatic Metastasis
18
2024
335
1.180
 Why?
Cell Proliferation
16
2023
2497
1.170
 Why?
Genes, erbB-2
8
2013
32
1.020
 Why?
Cell Cycle
5
2023
595
1.010
 Why?
Mammary Neoplasms, Experimental
6
2017
61
0.980
 Why?
MicroRNAs
6
2024
695
0.880
 Why?
Apoptosis
21
2018
2436
0.850
 Why?
Estrogen Receptor alpha
3
2023
154
0.830
 Why?
Estrogens
2
2023
364
0.750
 Why?
Cell Line, Tumor
23
2023
3538
0.750
 Why?
ErbB Receptors
6
2010
636
0.630
 Why?
Up-Regulation
3
2020
840
0.620
 Why?
Hormone Replacement Therapy
1
2020
107
0.590
 Why?
Immunohistochemistry
26
2020
1709
0.580
 Why?
Mammary Neoplasms, Animal
3
2018
35
0.560
 Why?
Triple Negative Breast Neoplasms
3
2016
219
0.550
 Why?
Caspases
5
2009
233
0.540
 Why?
Disease-Free Survival
11
2020
777
0.540
 Why?
Tumor Suppressor Protein p53
14
2011
530
0.510
 Why?
Retroperitoneal Space
3
2026
19
0.500
 Why?
Gene Expression Regulation, Neoplastic
18
2021
1429
0.470
 Why?
Antineoplastic Agents
10
2018
2218
0.460
 Why?
Prognosis
21
2020
4331
0.460
 Why?
Claudins
1
2016
23
0.460
 Why?
Receptor, IGF Type 1
3
2016
64
0.440
 Why?
Drug Resistance, Neoplasm
10
2023
889
0.440
 Why?
Trastuzumab
8
2016
119
0.420
 Why?
Quinazolines
3
2026
267
0.410
 Why?
Carcinogenesis
1
2016
226
0.400
 Why?
Antineoplastic Combined Chemotherapy Protocols
9
2015
1996
0.400
 Why?
Transcriptome
1
2020
1066
0.400
 Why?
Carcinoma, Ductal, Breast
5
2002
91
0.400
 Why?
Signal Transduction
16
2023
5234
0.400
 Why?
Postoperative Complications
1
2026
2962
0.380
 Why?
Estradiol
2
2009
517
0.380
 Why?
Genistein
2
2010
13
0.370
 Why?
Humans
95
2026
145625
0.370
 Why?
Receptors, Steroid
2
2012
41
0.370
 Why?
Hypoglycemic Agents
3
2017
1411
0.360
 Why?
Female
69
2026
79080
0.350
 Why?
Doxorubicin
10
2011
414
0.350
 Why?
Antineoplastic Agents, Hormonal
5
2020
196
0.340
 Why?
Antimetabolites, Antineoplastic
1
2012
108
0.340
 Why?
Receptors, Progesterone
6
2020
241
0.330
 Why?
Sweden
3
2026
114
0.320
 Why?
Teratoma
2
2022
121
0.310
 Why?
STAT3 Transcription Factor
1
2012
214
0.310
 Why?
Neoplasm Invasiveness
7
2016
503
0.310
 Why?
Genes, p53
5
2000
56
0.310
 Why?
Neoplasm Staging
9
2024
1486
0.300
 Why?
Mice
18
2023
18266
0.300
 Why?
Neoplasm Proteins
5
2016
443
0.290
 Why?
Glucose
1
2013
1051
0.270
 Why?
Middle Aged
33
2026
36359
0.270
 Why?
Glycoproteins
2
2005
355
0.260
 Why?
Intracellular Signaling Peptides and Proteins
2
2010
456
0.260
 Why?
Mammary Tumor Virus, Mouse
2
2004
42
0.260
 Why?
Mice, Transgenic
8
2018
2131
0.250
 Why?
MCF-7 Cells
4
2020
133
0.240
 Why?
Ejaculation
1
2026
5
0.240
 Why?
Carcinoma
4
1995
225
0.240
 Why?
Animals
23
2023
38030
0.240
 Why?
Neoplasm, Residual
2
2024
143
0.240
 Why?
Antibodies, Monoclonal
7
2013
1511
0.230
 Why?
Bromodeoxyuridine
2
1999
74
0.220
 Why?
Thiophenes
1
2026
117
0.220
 Why?
Multivariate Analysis
8
2005
1531
0.220
 Why?
Predictive Value of Tests
6
2024
2097
0.220
 Why?
Polymerase Chain Reaction
6
2021
1030
0.220
 Why?
Protein Kinase Inhibitors
3
2016
982
0.220
 Why?
Intraoperative Complications
1
2026
154
0.210
 Why?
Enzyme Activation
4
2009
758
0.210
 Why?
Tyrosine
2
2007
217
0.210
 Why?
Radiation Tolerance
1
2005
101
0.210
 Why?
Xenograft Model Antitumor Assays
3
2020
928
0.200
 Why?
Phosphorylation
5
2011
1717
0.200
 Why?
Cocarcinogenesis
1
2003
9
0.200
 Why?
Isoflavones
1
2003
25
0.190
 Why?
Cell Survival
5
2018
1102
0.190
 Why?
Survival Analysis
8
2005
1372
0.190
 Why?
Adult
22
2026
40821
0.190
 Why?
Paclitaxel
4
2015
258
0.190
 Why?
Chromosomes
1
2003
105
0.180
 Why?
Fluorouracil
6
2026
231
0.180
 Why?
Ki-67 Antigen
4
2014
119
0.180
 Why?
Cyclins
2
2000
77
0.180
 Why?
Chromosomes, Human, Pair 8
1
2002
40
0.180
 Why?
Gelsolin
1
2001
11
0.170
 Why?
Chromosome Aberrations
1
2002
167
0.170
 Why?
Orchiectomy
1
2021
72
0.170
 Why?
Proto-Oncogene Proteins c-ets
2
2020
54
0.170
 Why?
Cyclophosphamide
7
2011
275
0.170
 Why?
Breast
4
2018
154
0.160
 Why?
Retroperitoneal Neoplasms
1
2021
27
0.160
 Why?
Rats
7
2022
5574
0.160
 Why?
Caspase 3
4
2006
240
0.160
 Why?
Diet
3
2018
1271
0.160
 Why?
DNA-Binding Proteins
3
2020
1467
0.160
 Why?
Etoposide
1
2001
169
0.160
 Why?
Cell Division
6
2005
735
0.160
 Why?
Obesity
4
2022
3123
0.160
 Why?
Neoplastic Stem Cells
2
2014
402
0.150
 Why?
Mice, SCID
1
2020
360
0.150
 Why?
Phosphatidylinositol 3-Kinases
3
2011
384
0.150
 Why?
Proto-Oncogene Proteins
5
2008
615
0.150
 Why?
Drug Screening Assays, Antitumor
3
2016
194
0.150
 Why?
Transcription Factors
3
2020
1728
0.150
 Why?
TOR Serine-Threonine Kinases
3
2012
454
0.150
 Why?
Treatment Outcome
6
2026
11744
0.150
 Why?
Mitotic Index
1
1999
24
0.140
 Why?
Prospective Studies
4
2024
8087
0.140
 Why?
Carcinoma, Papillary
1
1999
83
0.140
 Why?
Mice, Inbred NOD
1
2020
598
0.140
 Why?
Receptors, Androgen
2
2017
149
0.140
 Why?
Antigens, Neoplasm
2
2009
271
0.140
 Why?
Chemotherapy, Adjuvant
5
2015
429
0.140
 Why?
Tumor Cells, Cultured
6
2009
878
0.140
 Why?
Ovarian Neoplasms
4
1995
598
0.140
 Why?
Drug Synergism
3
2018
353
0.140
 Why?
Aromatase
1
2018
37
0.140
 Why?
Kaplan-Meier Estimate
1
2020
959
0.130
 Why?
Receptor, Fibroblast Growth Factor, Type 1
1
2018
59
0.130
 Why?
HSP90 Heat-Shock Proteins
1
2018
47
0.130
 Why?
Phenylthiohydantoin
2
2017
44
0.130
 Why?
Colorectal Neoplasms
1
2026
870
0.130
 Why?
Down-Regulation
3
2010
612
0.130
 Why?
Autism Spectrum Disorder
1
2023
404
0.130
 Why?
In Situ Hybridization, Fluorescence
4
2008
333
0.130
 Why?
Ovariectomy
4
2022
164
0.130
 Why?
Tumor Burden
4
2022
326
0.130
 Why?
Poly(ADP-ribose) Polymerases
2
2009
88
0.130
 Why?
Organic Cation Transport Proteins
1
2017
25
0.120
 Why?
Postmenopause
5
2022
394
0.120
 Why?
Triazoles
1
2018
190
0.120
 Why?
Antibodies, Monoclonal, Humanized
5
2013
992
0.120
 Why?
Receptor Protein-Tyrosine Kinases
1
2018
226
0.120
 Why?
Smad Proteins
1
2016
42
0.120
 Why?
Cathepsin D
2
2002
22
0.110
 Why?
Gene Knock-In Techniques
1
2016
60
0.110
 Why?
Calcitriol
1
2016
59
0.110
 Why?
Ovary
1
2017
235
0.110
 Why?
Antibiotics, Antineoplastic
3
2009
140
0.110
 Why?
Proteins
2
1992
1021
0.110
 Why?
Male
9
2026
73014
0.110
 Why?
Gene Amplification
2
2009
116
0.110
 Why?
Protein Tyrosine Phosphatases
1
2016
166
0.110
 Why?
Fatty Acid Synthase, Type I
1
2014
11
0.110
 Why?
Immunoradiometric Assay
1
1994
1
0.100
 Why?
Immunoprecipitation
2
2011
150
0.100
 Why?
Mental Disorders
1
2023
1133
0.100
 Why?
Androgen Receptor Antagonists
1
2014
35
0.100
 Why?
Young Adult
4
2024
14240
0.100
 Why?
Postpartum Period
2
2014
377
0.100
 Why?
Disease Progression
6
2018
2857
0.100
 Why?
Insulin-Like Growth Factor I
1
2016
318
0.100
 Why?
Mice, Knockout
1
2020
3121
0.100
 Why?
Receptor, ErbB-4
2
2010
19
0.100
 Why?
Androgen Antagonists
1
2014
91
0.100
 Why?
Cyclin-Dependent Kinase Inhibitor p27
2
2010
64
0.100
 Why?
Transforming Growth Factor beta
1
2016
466
0.090
 Why?
Retrospective Studies
5
2026
17291
0.090
 Why?
Blotting, Western
3
2011
1176
0.090
 Why?
Adenocarcinoma
3
2012
927
0.090
 Why?
Aged
15
2026
26251
0.090
 Why?
Overnutrition
1
2012
28
0.090
 Why?
Vitamin D
1
2016
402
0.090
 Why?
Nucleic Acid Hybridization
2
2003
175
0.090
 Why?
DNA, Neoplasm
6
2005
160
0.090
 Why?
Aminosalicylic Acids
1
2012
10
0.090
 Why?
Benzenesulfonates
1
2012
23
0.090
 Why?
Carcinoma, Intraductal, Noninfiltrating
1
1992
61
0.090
 Why?
Proto-Oncogene Proteins c-bcl-2
2
2007
237
0.090
 Why?
Chromones
1
2011
43
0.090
 Why?
Gene Expression Profiling
2
2016
1790
0.090
 Why?
Genital Diseases, Female
1
1991
31
0.080
 Why?
RNA, Messenger
4
2016
2783
0.080
 Why?
Disease Models, Animal
4
2017
4565
0.080
 Why?
Dasatinib
1
2011
58
0.080
 Why?
Fluoxymesterone
1
1991
1
0.080
 Why?
Apoptosis Regulatory Proteins
1
2012
186
0.080
 Why?
Mitosis
3
2001
194
0.080
 Why?
Proportional Hazards Models
4
2005
1318
0.080
 Why?
S Phase
2
2010
77
0.080
 Why?
Reagent Kits, Diagnostic
1
1991
33
0.080
 Why?
Thiazoles
1
2011
139
0.080
 Why?
Morpholines
1
2011
130
0.080
 Why?
Cohort Studies
2
2020
6045
0.080
 Why?
Weight Gain
3
2022
561
0.080
 Why?
Chromosomes, Human, Pair 17
3
2002
54
0.080
 Why?
Proto-Oncogenes
1
1989
27
0.080
 Why?
Genital Neoplasms, Female
1
1991
100
0.080
 Why?
Neoplasm Metastasis
5
2005
693
0.080
 Why?
Dose-Response Relationship, Drug
2
2008
2018
0.070
 Why?
Radioisotopes
1
1989
37
0.070
 Why?
Flow Cytometry
3
2007
1160
0.070
 Why?
DNA Topoisomerases, Type II
1
2009
42
0.070
 Why?
Anthracyclines
1
2009
49
0.070
 Why?
Follow-Up Studies
5
2020
5397
0.070
 Why?
Aged, 80 and over
6
2002
8351
0.070
 Why?
Gene Deletion
2
2002
384
0.070
 Why?
MAP Kinase Signaling System
1
2010
306
0.070
 Why?
AMP-Activated Protein Kinases
1
2009
192
0.070
 Why?
Reverse Transcriptase Polymerase Chain Reaction
2
2010
973
0.070
 Why?
Pyrimidines
1
2011
530
0.070
 Why?
RNA, Small Interfering
2
2007
630
0.070
 Why?
Mice, Nude
1
2009
665
0.060
 Why?
Epithelial Cells
1
2014
1118
0.060
 Why?
Gene Dosage
1
2008
146
0.060
 Why?
Mutation
3
1995
4082
0.060
 Why?
Protein Structure, Tertiary
1
2009
834
0.060
 Why?
Reproducibility of Results
3
2023
3396
0.060
 Why?
Immunoenzyme Techniques
3
1999
196
0.060
 Why?
Time Factors
4
2015
7079
0.060
 Why?
Energy Metabolism
1
2012
930
0.060
 Why?
Proto-Oncogene Proteins c-akt
3
2016
438
0.060
 Why?
Enzyme Precursors
1
2006
15
0.060
 Why?
Thymidylate Synthase
1
2026
13
0.060
 Why?
Cell Nucleus
4
2006
584
0.060
 Why?
Receptor, Notch1
1
2006
62
0.060
 Why?
Aging
4
2003
1983
0.060
 Why?
Multigene Family
2
2003
209
0.060
 Why?
Lamin Type B
1
2005
6
0.060
 Why?
Epigenesis, Genetic
1
2010
705
0.060
 Why?
Mitochondria
3
2008
996
0.050
 Why?
Herpes Simplex
1
2006
102
0.050
 Why?
Survival Rate
4
2020
2078
0.050
 Why?
Age Factors
3
2003
3321
0.050
 Why?
Cell Nucleolus
1
2005
21
0.050
 Why?
Herpesvirus 1, Human
1
2006
87
0.050
 Why?
Cyclin-Dependent Kinase Inhibitor p21
2
2007
104
0.050
 Why?
Benzamides
2
2017
226
0.050
 Why?
Antineoplastic Agents, Phytogenic
2
2007
178
0.050
 Why?
Nitriles
2
2017
211
0.050
 Why?
Feedback
1
2005
180
0.050
 Why?
RNA Interference
3
2015
470
0.050
 Why?
Protein Kinases
1
2006
311
0.050
 Why?
Tacrolimus Binding Protein 1A
1
2003
10
0.050
 Why?
Tacrolimus Binding Proteins
1
2003
25
0.050
 Why?
Rats, Wistar
2
2017
449
0.050
 Why?
Tumor Microenvironment
2
2018
745
0.050
 Why?
Mice, Inbred Strains
1
2004
384
0.050
 Why?
Estrogens, Non-Steroidal
1
2003
10
0.050
 Why?
Genes, Tumor Suppressor
1
2003
84
0.050
 Why?
Phytoestrogens
1
2003
17
0.050
 Why?
Adipose Tissue
2
2018
641
0.050
 Why?
Estrogen Antagonists
1
2003
37
0.050
 Why?
Plant Preparations
1
2003
37
0.050
 Why?
Cell Line
2
2003
2809
0.050
 Why?
Actins
1
2005
422
0.050
 Why?
Anticarcinogenic Agents
1
2003
63
0.050
 Why?
Chromosome Banding
1
2002
20
0.050
 Why?
Chromosomes, Human, Pair 16
1
2002
36
0.050
 Why?
Mammary Glands, Animal
1
2003
124
0.050
 Why?
Embryoid Bodies
1
2022
7
0.040
 Why?
Transfection
3
2015
914
0.040
 Why?
3' Untranslated Regions
2
2014
152
0.040
 Why?
Rodentia
1
2022
62
0.040
 Why?
Trefoil Factor-1
2
1992
2
0.040
 Why?
Fallopian Tubes
2
1991
33
0.040
 Why?
alpha-Fetoproteins
1
2021
42
0.040
 Why?
In Situ Nick-End Labeling
1
2001
120
0.040
 Why?
Chorionic Gonadotropin
1
2021
77
0.040
 Why?
RNA, Catalytic
1
2002
191
0.040
 Why?
Nuclear Proteins
2
2000
739
0.040
 Why?
DNA Fragmentation
1
2001
42
0.040
 Why?
Plasmids
1
2002
372
0.040
 Why?
Inhibitory Concentration 50
1
2001
90
0.040
 Why?
Fibrosis
1
2023
568
0.040
 Why?
Antigens, Nuclear
1
2000
14
0.040
 Why?
RNA Stability
1
2021
119
0.040
 Why?
Breast Diseases
1
2000
22
0.040
 Why?
Enhancer Elements, Genetic
1
2000
190
0.040
 Why?
Integrin beta3
2
2013
14
0.040
 Why?
Tumor Suppressor Proteins
2
1992
314
0.040
 Why?
Telomerase
1
2001
252
0.040
 Why?
N-Glycosyl Hydrolases
1
1998
6
0.030
 Why?
Methylnitrosourea
1
2018
7
0.030
 Why?
DNA Glycosylases
1
1998
10
0.030
 Why?
Trans-Activators
1
2000
371
0.030
 Why?
Loss of Function Mutation
1
2018
47
0.030
 Why?
G2 Phase Cell Cycle Checkpoints
1
2018
43
0.030
 Why?
Antibodies
1
2000
395
0.030
 Why?
Codon
3
1993
92
0.030
 Why?
NF-kappa B
1
2002
674
0.030
 Why?
Half-Life
1
2018
157
0.030
 Why?
Case-Control Studies
2
2023
3633
0.030
 Why?
Stromal Cells
1
2018
123
0.030
 Why?
Hyaluronan Receptors
1
1998
105
0.030
 Why?
Calcium-Calmodulin-Dependent Protein Kinases
1
1998
165
0.030
 Why?
Gene Expression
3
2013
1461
0.030
 Why?
Organic Cation Transporter 2
1
2017
8
0.030
 Why?
Cell Movement
1
2001
950
0.030
 Why?
Extracellular Matrix Proteins
1
1998
156
0.030
 Why?
Steroids
1
2017
160
0.030
 Why?
Proto-Oncogene Proteins pp60(c-src)
1
2016
14
0.030
 Why?
Antigens, CD
2
2014
559
0.030
 Why?
DNA Repair
1
1998
254
0.030
 Why?
Oncogenes
1
2016
113
0.030
 Why?
Phosphatidylinositol 3-Kinase
1
2015
24
0.030
 Why?
Chromatography, Liquid
1
2017
452
0.030
 Why?
Oncogene Proteins
1
1995
61
0.030
 Why?
Analysis of Variance
2
2014
1293
0.030
 Why?
RNA
1
2001
925
0.030
 Why?
Homeodomain Proteins
1
2018
525
0.030
 Why?
Tosyl Compounds
1
2014
17
0.030
 Why?
Gene Expression Regulation, Enzymologic
1
2015
266
0.030
 Why?
Integrin alpha6
1
2013
9
0.030
 Why?
Mass Spectrometry
1
2017
728
0.030
 Why?
Mammary Glands, Human
1
2014
71
0.030
 Why?
Leukocyte Common Antigens
1
2014
86
0.030
 Why?
Adolescent
3
2024
22451
0.030
 Why?
Antigens, Differentiation, Myelomonocytic
1
2014
66
0.020
 Why?
Parity
1
2014
112
0.020
 Why?
Neovascularization, Pathologic
1
1995
285
0.020
 Why?
Transplantation, Heterologous
1
2014
165
0.020
 Why?
Immunoassay
1
1994
108
0.020
 Why?
Anilides
1
2014
82
0.020
 Why?
Neoplasm Transplantation
1
2014
238
0.020
 Why?
Premenopause
1
2014
129
0.020
 Why?
Tomography, X-Ray Computed
1
2024
2766
0.020
 Why?
Testosterone
1
2017
419
0.020
 Why?
bcl-2-Associated X Protein
2
2007
53
0.020
 Why?
Sirolimus
2
2006
282
0.020
 Why?
Organ Specificity
1
2013
306
0.020
 Why?
Interleukin-6
1
2017
782
0.020
 Why?
Inhibitor of Apoptosis Proteins
1
2013
45
0.020
 Why?
Immune System
1
2014
181
0.020
 Why?
Lactation
1
2014
193
0.020
 Why?
Lipogenesis
1
2012
62
0.020
 Why?
Point Mutation
1
1993
232
0.020
 Why?
Brain Neoplasms
2
1993
1324
0.020
 Why?
Molecular Targeted Therapy
1
2015
446
0.020
 Why?
Tumor Necrosis Factor-alpha
2
2007
1223
0.020
 Why?
Astrocytoma
1
1993
128
0.020
 Why?
Broad Ligament
1
1991
1
0.020
 Why?
Neoplasms
2
2012
2944
0.020
 Why?
Gene Knockdown Techniques
1
2013
334
0.020
 Why?
Peritoneum
1
1991
44
0.020
 Why?
Mucins
1
1991
75
0.020
 Why?
Pregnancy Complications, Neoplastic
1
1991
64
0.020
 Why?
Blotting, Northern
1
2010
197
0.020
 Why?
Glycolysis
1
2012
341
0.020
 Why?
Evaluation Studies as Topic
1
1991
160
0.020
 Why?
Hormones
1
1991
134
0.020
 Why?
Cells, Cultured
2
2013
4112
0.020
 Why?
In Situ Hybridization
1
2010
317
0.020
 Why?
Soft Tissue Neoplasms
1
1991
133
0.020
 Why?
Precipitin Tests
1
1989
90
0.020
 Why?
Pilot Projects
1
2015
1878
0.020
 Why?
Pregnancy
2
2014
7217
0.020
 Why?
Radionuclide Imaging
1
1989
116
0.020
 Why?
Odds Ratio
1
1992
1070
0.020
 Why?
Glioblastoma
1
1993
349
0.020
 Why?
Oligonucleotide Array Sequence Analysis
1
2010
751
0.020
 Why?
Protein Multimerization
1
2010
201
0.020
 Why?
Risk Factors
1
2003
10840
0.020
 Why?
Lymph Nodes
1
1991
511
0.020
 Why?
Drug Interactions
1
2009
403
0.020
 Why?
Cytochromes c
1
2007
53
0.020
 Why?
Membrane Potential, Mitochondrial
1
2007
74
0.020
 Why?
Apoptotic Protease-Activating Factor 1
1
2007
2
0.020
 Why?
Caspase 10
1
2006
5
0.020
 Why?
Caspase 2
1
2006
12
0.020
 Why?
Amino Acid Sequence
3
1998
2088
0.020
 Why?
Caspase 8
1
2006
48
0.020
 Why?
Caspase 9
1
2006
54
0.020
 Why?
Cysteine Endopeptidases
1
2006
80
0.010
 Why?
Leukemia-Lymphoma, Adult T-Cell
1
2006
17
0.010
 Why?
Caspase 7
1
2006
21
0.010
 Why?
Isoenzymes
1
2007
294
0.010
 Why?
Eukaryotic Initiation Factor-4E
1
2006
32
0.010
 Why?
Vero Cells
1
2006
84
0.010
 Why?
Cytosol
1
2006
215
0.010
 Why?
Base Sequence
2
2003
2119
0.010
 Why?
Biomarkers
1
2017
4329
0.010
 Why?
Promoter Regions, Genetic
1
2010
1236
0.010
 Why?
Virus Assembly
1
2006
81
0.010
 Why?
Taxoids
1
2004
115
0.010
 Why?
Protein Binding
1
2010
2239
0.010
 Why?
DNA, Complementary
1
2003
269
0.010
 Why?
Protein Processing, Post-Translational
1
2006
485
0.010
 Why?
Melanoma, Experimental
1
2003
106
0.010
 Why?
Americas
1
2002
27
0.010
 Why?
Urokinase-Type Plasminogen Activator
1
2002
25
0.010
 Why?
Vascular Endothelial Growth Factors
1
2002
77
0.010
 Why?
Endothelial Growth Factors
1
2002
61
0.010
 Why?
Lymphokines
1
2002
127
0.010
 Why?
Plasminogen Activator Inhibitor 1
1
2002
83
0.010
 Why?
Platelet Membrane Glycoproteins
1
2002
31
0.010
 Why?
Cell Adhesion
1
2003
447
0.010
 Why?
Platelet Endothelial Cell Adhesion Molecule-1
1
2002
49
0.010
 Why?
Gene Targeting
1
2002
76
0.010
 Why?
Exons
2
1993
361
0.010
 Why?
Mice, Inbred C57BL
2
2003
6021
0.010
 Why?
Europe
1
2002
420
0.010
 Why?
Templates, Genetic
1
2001
63
0.010
 Why?
Molecular Sequence Data
2
1998
2835
0.010
 Why?
Substrate Specificity
1
2002
387
0.010
 Why?
DNA, Superhelical
1
2000
11
0.010
 Why?
DNA Footprinting
1
2000
33
0.010
 Why?
Intercellular Signaling Peptides and Proteins
1
2002
372
0.010
 Why?
Mice, Inbred BALB C
1
2003
1244
0.010
 Why?
Data Interpretation, Statistical
1
2002
365
0.010
 Why?
Genes, erbB
1
2000
2
0.010
 Why?
Ploidies
1
2000
21
0.010
 Why?
Repetitive Sequences, Nucleic Acid
1
2000
116
0.010
 Why?
Macromolecular Substances
1
2000
205
0.010
 Why?
Pathology, Clinical
1
2000
29
0.010
 Why?
Vascular Endothelial Growth Factor A
1
2002
543
0.010
 Why?
Gene Silencing
1
2000
200
0.010
 Why?
Forecasting
1
2000
386
0.010
 Why?
Multicenter Studies as Topic
1
2000
413
0.010
 Why?
Genetic Therapy
1
2000
303
0.010
 Why?
Receptors, Cell Surface
1
2000
371
0.010
 Why?
Nucleic Acid Conformation
1
2000
723
0.010
 Why?
Binding Sites
1
2000
1306
0.010
 Why?
Chromosomes, Human, Pair 13
1
1996
15
0.010
 Why?
ras Proteins
1
1998
148
0.010
 Why?
Chromosomes, Human, Pair 3
1
1996
43
0.010
 Why?
Chromosomes, Human, Pair 11
1
1996
60
0.010
 Why?
Immunoblotting
1
1997
294
0.010
 Why?
Heterozygote
1
1996
310
0.010
 Why?
Societies, Medical
1
2000
901
0.010
 Why?
Hyaluronic Acid
1
1998
226
0.010
 Why?
Adenine
1
1998
338
0.010
 Why?
Polymorphism, Single-Stranded Conformational
1
1995
26
0.010
 Why?
Protein Isoforms
1
1997
388
0.010
 Why?
Melanoma
1
2002
764
0.010
 Why?
Cyclin D1
1
1995
64
0.010
 Why?
Factor VIII
1
1995
107
0.010
 Why?
Single-Blind Method
1
1995
312
0.010
 Why?
United States
2
2004
16041
0.010
 Why?
Observer Variation
1
1995
355
0.010
 Why?
Transcription, Genetic
1
2000
1429
0.010
 Why?
Randomized Controlled Trials as Topic
1
2000
1754
0.010
 Why?
Alleles
1
1996
900
0.010
 Why?
Biopsy
1
1995
1073
0.010
 Why?
Proliferating Cell Nuclear Antigen
1
1991
48
0.010
 Why?
Peripheral Nerves
1
1991
73
0.000
 Why?
Polymorphism, Genetic
1
1993
611
0.000
 Why?
Risk Assessment
1
2000
3678
0.000
 Why?
DNA
1
1996
1418
0.000
 Why?
Protein Conformation
1
1993
914
0.000
 Why?
Lung Neoplasms
1
2002
2674
0.000
 Why?
Cerebral Cortex
1
1991
481
0.000
 Why?
Glioma
1
1991
425
0.000
 Why?
Child
1
1993
22638
0.000
 Why?
Thor's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (458) concept(s)
_
Co-Authors Expand Description
See all (25) people
_
Similar People Expand Description
See all (60) people
_
Same Department Expand Description
Search Department
Physical Neighbors Expand Description
_

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)